Relations (1)

related 2.00 — strongly supporting 3 facts

MDMA is categorized alongside hallucinogens in clinical reviews of mental health treatments [1] and is frequently grouped with psychedelics in studies examining their shared impact on episodic memory [2]. Furthermore, MDMA is explicitly distinguished from classic hallucinogens in pharmacological research regarding its unique mechanism of action as an entactogen [3].

Facts (3)

Sources
Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer 1 fact
claimDavid E. Nichols identified a new therapeutic class of drugs called entactogens in 1986, distinguishing them from MDMA, MBDB, and classic hallucinogens based on their mechanism of action.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua David B Yaden, Matthew W Johnson, Roland R Griffiths, Manoj K Doss, Albert Garcia-Romeu, Sandeep Nayak, Natalie Gukasyan, Brian N Mathur, Frederick S Barrett · Oxford University Press 1 fact
claimSedatives (alcohol, zolpidem, triazolam), dissociatives (ketamine, dextromethorphan), psychedelics (psilocybin, MDMA), stimulants (dextroamphetamine, dextromethamphetamine), and cannabinoids (THC) each have idiosyncratic effects on episodic memory, differentially impairing certain mnemonic processes while sparing or facilitating others.
Psychedelics, Sociality, and Human Evolution frontiersin.org Frontiers 1 fact
referenceDe Gregorio et al. (2021a) reviewed preclinical and clinical studies on the use of hallucinogens, specifically LSD, psilocybin, MDMA, and ketamine, in mental health, published in the Journal of Neuroscience.